|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Cash flows provided by (disbursed for) operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Stock-based compensation | |||||
| Impairment of assets | |||||
| Loss reclassified from accumulated other comprehensive income to net income | |||||
| Deferred income taxes | |||||
| Provision for inventory obsolescence | |||||
| Allowances for accounts receivable | |||||
| Pension and postretirement plans expense | |||||
| Other | |||||
| Qualified pension plan contributions | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Hedging activities, net | |||||
| Accounts payable | |||||
| Other assets and accrued liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows provided by (disbursed for) investing activities: | |||||
| Purchases of property, plant and equipment | |||||
| Repurchase of independent distributor territories | |||||
| Cash paid at issuance of notes receivable | |||||
| Principal payments from notes receivable | |||||
| Proceeds from sales of property, plant and equipment | |||||
| Proceeds from insurance settlement | |||||
| Acquisition of business | |||||
| Investment in unconsolidated affiliate | |||||
| Other investing activities | |||||
| Net cash disbursed for investing activities | |||||
| Cash flows provided by (disbursed for) financing activities: | |||||
| Dividends paid, including dividends on share-based payment awards | |||||
| Payments for debt issuance costs | |||||
| Stock repurchases | |||||
| Change in bank overdrafts | |||||
| Proceeds from debt borrowings | |||||
| Debt obligation payments | |||||
| Payments on financing leases | |||||
| Net cash provided by (disbursed for) financing activities | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Schedule of non-cash investing and financing activities: | |||||
| Issuance of executive deferred compensation plan common stock | |||||
| Right-of-use assets obtained in exchange for new financing lease liabilities | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Issuance of notes receivable on new distribution territories, net | |||||
| Distributor routes sold with deferred gains, net | |||||
| Purchase of property, plant and equipment included in accounts payable | |||||
| Cash paid during the period for: | |||||
| Interest | |||||
| Income taxes paid, net of refunds of $5,825, $337 and $120, respectively | |||||
Loading...